ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 445 filers reported holding ENCOMPASS HEALTH CORP in Q4 2018. The put-call ratio across all filers is 1.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $207,000 | -26.3% | 3,689 | -6.8% | 0.00% | 0.0% |
| Q1 2022 | $281,000 | +8.9% | 3,958 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $258,000 | -11.0% | 3,958 | +2.6% | 0.00% | 0.0% |
| Q3 2021 | $290,000 | +1.8% | 3,858 | +5.5% | 0.00% | 0.0% |
| Q2 2021 | $285,000 | -5.0% | 3,658 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $300,000 | -7.1% | 3,658 | -6.3% | 0.00% | -50.0% |
| Q4 2020 | $323,000 | +27.2% | 3,906 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $254,000 | +7.6% | 3,906 | +2.5% | 0.00% | 0.0% |
| Q2 2020 | $236,000 | -3.3% | 3,809 | 0.0% | 0.00% | -50.0% |
| Q1 2020 | $244,000 | -7.6% | 3,809 | 0.0% | 0.00% | +100.0% |
| Q4 2019 | $264,000 | +18.9% | 3,809 | +8.6% | 0.00% | 0.0% |
| Q3 2019 | $222,000 | 0.0% | 3,507 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $222,000 | +8.3% | 3,507 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $205,000 | -5.1% | 3,507 | 0.0% | 0.00% | -50.0% |
| Q4 2018 | $216,000 | -20.9% | 3,507 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $273,000 | +15.2% | 3,507 | 0.0% | 0.00% | +100.0% |
| Q2 2018 | $237,000 | – | 3,507 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 798,931 | $53,656,206 | 4.60% |
| Orchard Capital Management, LLC | 135,466 | $9,097,897 | 3.36% |
| Sivik Global Healthcare LLC | 90,000 | $6,044 | 3.05% |
| BERNZOTT CAPITAL ADVISORS | 128,663 | $8,641,007 | 2.98% |
| REINHART PARTNERS, LLC. | 746,752 | $50,151,893 | 2.60% |
| Integral Health Asset Management, LLC | 250,000 | $16,790,000 | 2.32% |
| Leeward Investments, LLC - MA | 562,001 | $37,743,987 | 1.93% |
| Copeland Capital Management, LLC | 1,277,690 | $85,809,665 | 1.84% |
| Magnetar Financial LLC | 1,060,733 | $71,238,828 | 1.82% |
| Advantage Alpha Capital Partners LP | 122,252 | $8,210,444 | 1.72% |